NeurologyPub Date : 2024-11-12Epub Date: 2024-10-04DOI: 10.1212/WNL.0000000000209949
Malik Ghannam, Abdullah M Al-Qudah, Qasem N Alshaer, Richard Kronmal, George Ntaios, Christopher A Childs, W T Longstreth, Ashraf Alsawareah, Timea Keller, Lina M Serna-Higuita, Tobias Geisler, Karen Furie, Jeffrey L Saver, Scott E Kasner, Mitchell S V Elkind, David Tirschwell, Sven Poli, Hooman Kamel, Shadi Yaghi
{"title":"Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source: A Meta-Analysis of Randomized Controlled Trials.","authors":"Malik Ghannam, Abdullah M Al-Qudah, Qasem N Alshaer, Richard Kronmal, George Ntaios, Christopher A Childs, W T Longstreth, Ashraf Alsawareah, Timea Keller, Lina M Serna-Higuita, Tobias Geisler, Karen Furie, Jeffrey L Saver, Scott E Kasner, Mitchell S V Elkind, David Tirschwell, Sven Poli, Hooman Kamel, Shadi Yaghi","doi":"10.1212/WNL.0000000000209949","DOIUrl":"10.1212/WNL.0000000000209949","url":null,"abstract":"<p><strong>Background and objectives: </strong>The term \"embolic stroke of undetermined source\" (ESUS) encompasses a substantial but heterogeneous population of patients with ischemic stroke, underscoring the importance of identifying personalized treatment strategies. In subgroups of patients randomized in ESUS trials, we evaluated the effectiveness of anticoagulation compared with antiplatelet therapy in secondary ischemic stroke prevention.</p><p><strong>Methods: </strong>A study-level meta-analysis was conducted on randomized controlled trials of patients with ESUS, comparing anticoagulation with antiplatelet therapy. The primary efficacy outcome was recurrent ischemic stroke, and safety outcomes were major bleeding and death. Subgroups assessed were age, sex, presence of patent foramen ovale (PFO), left atrial enlargement (LAE), and atrial cardiopathy. Pooled risk ratios (RRs) were meta-analyzed. Cochrane Risk of Bias Tool 2.0 was used for risk-of-bias assessment.</p><p><strong>Results: </strong>A total of 7 randomized controlled trials involving 14,804 patients were analyzed, with 7,406 patients treated with anticoagulation and 7,398 treated with antiplatelet therapy. Compared with antiplatelet therapy, anticoagulation was associated with a similar rate of recurrent ischemic stroke (RR 0.91, 95% CI 0.80-1.05; <i>I</i><sup>2</sup> = 0%). In ESUS with PFO, anticoagulation was associated with significantly lower risk of ischemic stroke (RR 0.59, 95% CI 0.35-0.98; <i>I</i><sup>2</sup> = 0%). Heterogeneity was present in those with LAE: antiplatelet therapy was superior in trials allowing cardiac monitoring after randomization (RR 6.65, 95% CI 1.26-35.08; <i>I</i><sup>2</sup> = 0%), but anticoagulation was superior in trials prohibiting cardiac monitoring after randomization (RR 0.25 95% CI 0.07-0.89). Subgroups based on age, sex, or presence of atrial cardiopathy did not benefit from anticoagulation over antiplatelet therapy.</p><p><strong>Discussion: </strong>In this meta-analysis, an empiric anticoagulation approach is not beneficial for patients with ESUS. This finding highlights the importance of an individualized treatment strategy. Such a strategy should include prolonged cardiac monitoring for atrial fibrillation, particularly in patients with moderate-to-severe LAE. Anticoagulation treatment showed promise in patients with medically treated PFO. Other subgroups did not benefit from anticoagulation therapy. Large prospective studies within ESUS subgroups are needed to validate our findings.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209949"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-10-04DOI: 10.1212/WNL.0000000000209929
Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage Alvarez, Jeremy Abramson, Andrew R Branagan, Yongli Ji, Yi-Bin A Chen, Alyssa R Letourneau, Brian V Nahed, Isabel C Arrillaga-Romany, Nancy Wang, Jorg Dietrich
{"title":"Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy.","authors":"Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage Alvarez, Jeremy Abramson, Andrew R Branagan, Yongli Ji, Yi-Bin A Chen, Alyssa R Letourneau, Brian V Nahed, Isabel C Arrillaga-Romany, Nancy Wang, Jorg Dietrich","doi":"10.1212/WNL.0000000000209929","DOIUrl":"https://doi.org/10.1212/WNL.0000000000209929","url":null,"abstract":"","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209929"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-10-11DOI: 10.1212/WNL.0000000000209947
Peter C Austin, Moira K Kapral, Manav V Vyas, Jiming Fang, Amy Ying Xin Yu
{"title":"Using Multilevel Models and Generalized Estimating Equation Models to Account for Clustering in Neurology Clinical Research.","authors":"Peter C Austin, Moira K Kapral, Manav V Vyas, Jiming Fang, Amy Ying Xin Yu","doi":"10.1212/WNL.0000000000209947","DOIUrl":"10.1212/WNL.0000000000209947","url":null,"abstract":"<p><p>In clinical and health services research, clustered data (also known as data with a multilevel or hierarchical structure) are frequently encountered. For example, patients may be clustered or nested within hospitals. Understanding when data have a multilevel structure is important because clustering of individuals can induce a homogeneity in outcomes within clusters, so that, even after adjusting for measured covariates, outcomes for 2 individuals in the same cluster are more likely to be similar than outcomes for 2 individuals from different clusters. Using conventional statistical regression models to analyze clustered data can result in incorrect conclusions being drawn. In particular, estimated CIs may be artificially narrow, and significance levels may be artificially low. As a result, one may conclude that there is a statistically significant association when there is none. To avoid this problem, investigators should ensure that their analyses use techniques that account for clustering of data. Generalized linear models estimated using generalized estimating equation (GEE) methods and multilevel regression models (also known as hierarchical regression models, mixed-effects models, or random-effects models) are two such techniques. We provide an introduction to clustered or multilevel data and describe how GEE models or multilevel models can be used for the analysis of multilevel data.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209947"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469681/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-09-30DOI: 10.1212/WNL.0000000000209968
{"title":"Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.","authors":"","doi":"10.1212/WNL.0000000000209968","DOIUrl":"https://doi.org/10.1212/WNL.0000000000209968","url":null,"abstract":"","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209968"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-09-27DOI: 10.1212/WNL.0000000000209931
Aaron S Zelikovich, Safa Kaleem, Gary Kocharian, Nalini Tata, Alison Seitz, Alexander E Merkler
{"title":"Teaching NeuroImage: Hemorrhagic Arachnoid Cyst.","authors":"Aaron S Zelikovich, Safa Kaleem, Gary Kocharian, Nalini Tata, Alison Seitz, Alexander E Merkler","doi":"10.1212/WNL.0000000000209931","DOIUrl":"https://doi.org/10.1212/WNL.0000000000209931","url":null,"abstract":"","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209931"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-10-04DOI: 10.1212/WNL.0000000000209965
{"title":"Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillar and Distal Myopathies: Experience From the Italian Network.","authors":"","doi":"10.1212/WNL.0000000000209965","DOIUrl":"https://doi.org/10.1212/WNL.0000000000209965","url":null,"abstract":"","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209965"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-10-07DOI: 10.1212/WNL.0000000000210006
{"title":"Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study.","authors":"","doi":"10.1212/WNL.0000000000210006","DOIUrl":"https://doi.org/10.1212/WNL.0000000000210006","url":null,"abstract":"","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e210006"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeurologyPub Date : 2024-11-12Epub Date: 2024-10-08DOI: 10.1212/WNL.0000000000209881
Tekla A Fodor, Maria T Schmook, Christof Brücke
{"title":"Pearls & Oy-sters: Neurologic Involvement in Shiga Toxin-Associated Hemolytic Uremic Syndrome.","authors":"Tekla A Fodor, Maria T Schmook, Christof Brücke","doi":"10.1212/WNL.0000000000209881","DOIUrl":"10.1212/WNL.0000000000209881","url":null,"abstract":"<p><p>Shiga toxin-producing <i>Escherichia coli</i> (STEC) is among the most common pathogens that cause bacterial enteritis. They can also lead to extraintestinal manifestations including hemolytic uremic syndrome (HUS), which is defined by the triad of hemolytic anemia, thrombocytopenia, and acute renal dysfunction due to Shiga toxin-mediated damage to the vascular endothelium with a subsequent inflammatory reaction and thrombotic microangiopathy. The thrombotic microangiopathy mainly affects the small blood vessels of the kidneys and brain. Neurologic involvement, especially in adults, is rare but can include nonspecific symptoms such as a decreased consciousness, altered mental status, seizures, and hyperreflexia. Although HUS is often assumed to cause isolated involvement of small vessels, in this case report, a 52-year-old woman with a STEC-HUS-encephalopathy developed multiple craniocervical dissections during the course of her disease in the absence of any trauma or cardiovascular risk factors. This case thus could possibly indicate that Shiga toxin-mediated damages are not limited to the small vessels but can also affect larger vessels.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 9","pages":"e209881"},"PeriodicalIF":7.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}